Drugs Made In America Acquisition II Corp.
DMIIR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.65M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.65 Million |
|---|---|
| Enterprise Value | $2.93 Million |
| Earnings per Share | $0.07 |
| Beta | 2.05 |
| Outstanding Shares | 50,000,000 |
Return
| Return on Equity | 2.62% |
|---|---|
| Return on Assets | 2.53% |
| Return on Invested Capital | -0.28% |
Valuation & Multiples
| P/E Ratio | 0.39 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.02 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Drugs Made In America Acquisition II Corp. Ordinary Shares
2 employees
CEO: Roger Bendelac
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a rec...